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Background: Long segment laryngotracheoesophageal clefts (LTECs) are very rare
large‐airway malformations. Over the last 40 years mortality rates declined
substantially due to improved intensive care and surgical procedures. Nevertheless,
long‐term morbidity, comorbidity, and clinical outcomes have rarely been assessed
systematically.
Methods: In this retrospective case series, the clinical presentation, comorbidities,
treatment, and clinical outcomes of all children with long‐segment LTEC that
were seen at our department in the last 15 years were collected and analyzed
systematically.
Results: Nine children were diagnosed with long segment LTEC (four children with
LTEC type III and five patients with LTEC type IV). All children had additional
tracheobronchial, gastrointestinal, or cardiac malformations. Tracheostomy for long‐
time ventilation and jejunostomy for adequate nutrition was necessary in all cases.
During follow‐up one child died from multiorgan failure due to sepsis at the age of
43 days. The clinical course of the other eight children (median follow‐up time
5.2 years) was stable. Relapses of the cleft, recurrent aspirations, and respiratory
tract infections led to repeated hospital admissions.
Conclusions: Long‐segment LTECs are consistently associated with additional
malformations, which substantially influence long‐term morbidity. For optimal
management, a multidisciplinary approach is essential.
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1 | INTRODUCTION
Laryngotracheoesophageal clefts (LTEC) are rare malformations
initially described by Richter in 1792.1 Incidence ranges from 1:10,000
to 1:20,000 with a male predominance.2–5 As most cases are sporadic,
the etiology of LTEC is considered multifactorial.4,6 Leading symptoms
are neonatal respiratory distress, inspiratory stridor, hoarseness,
chronic cough, recurrent aspirations, recurrent pulmonary infections,
and dysphagia.7–11 Variable mortality rates have been published over
the years for long segment LTEC and declined substantially from over
90% in the early 1980s to 50% in more recent series.12–14
A variety of classifications for LTEC have been published. The
most widely used classification was proposed by Benjamin and Inglis8
in 1989 and is based on the caudal extension of the LTEC (Figure 1).
It divides LTEC into four types: (1) type I extends to the level of the
vocal cords, (2) type II extends below the vocal cords into the cricoid
cartilage, (3) type III extends through the cricoid cartilage to the
cervical trachea/esophagus, and (4) type IV extends to the level of
the thoracic trachea.15 To differentiate long segment LTEC types III
and IV, the level of the thoracic inlet in relation to the distal cleft
extension needs to be determined by endoscopy.3 Other classifica-
tions are used less often.6,15
The embryological development of LTEC is not fully understood.
Two contrasting theories exist explaining how the normal respiratory
system is separated from the gastrointestinal tract.16 According to
these long segment LTECs may be (1) the result of apoptosis of a
primary existing separation or (2) deficient separation of two primary
connected tubes.4,14,17–22
The goal of surgical treatment is to resolve impaired feeding
and minimize respiratory complications, which may be achieved
only in a stepwise approach. Endoscopic or open techniques have
been published.2–4,12,17,23–25 For long segment LTEC, an open
surgical approach is the mainstay. An endoscopic cleft repair can
be considered when adequate visualization can be achieved,25
tubeless anesthesia with or without spontaneous ventilation or
jet‐ventilation is possible26 limiting the endoscopic approach
mostly to patients with no or restricted involvement of the
trachea (mostly LTEC type I or II and in certain exceptional cases
LTEC III).10,15,27
Only small case series and single case reports have been pub-
lished, focusing on various surgical procedures and mortality. To our
knowledge, no comprehensive study about long‐term morbidity has
been published before. The goal of this analysis is to report
comorbidities, morbidity, and long‐term clinical outcome in a com-
prehensive fashion.
2 | METHODS
2.1 | Study cohort
We identified children diagnosed with long segment LTEC by going
consecutively through all surgical reports of children admitted to our
department from 2004 to 2020. Diagnosis and classification were
made with rigid bronchoscopy by determining the distal cleft
extension in relation to the thoracic inlet. Clinical information was
collected retrospectively from the clinical charts. All children un-
derwent structured evaluation by a pediatric pneumologist, gastro-
enterologist, nutrition expert, and cardiologist. Demographic data,
information on the clinical presentation, comorbidities, time from
symptom onset to diagnosis, treatment, and clinical outcome data
were collected.
2.2 | Statistics and ethics statement
All data were anonymized and analyzed retrospectively. Due to the
small number of included patients, for reliable results only de-
scriptive statistics were performed. Values are indicated as median
and ranges. The study was approved by the Ethics Commission at the
Ludwig‐Maximilians University of Munich, München (EK250311).
3 | RESULTS
3.1 | Study cohort
Between 2004 and 2020, nine children (four with LTEC type III and
five with LTEC type IV) were seen at our department (Table 1a,b).
Five children were male and four females. More than half (5/9) of the
children were born preterm. In six patients, a prenatal poly-
hydramnion was reported, and seven patients were born via cesar-
ean section. In all patients, the diagnosis was made within the first
4 weeks of life (median: 5 days, range: 2–28 days) suspected after
recurrent aspirations, repeatedly misplaced tracheal tubes, or a
malformed larynx seen during first intubation.
3.2 | Comorbidities
Comorbidities were diagnosed in every child. In three children an
underlying genetic syndrome was identified (Opitz G/BBB syn-
drome, trisomy 21, and monosomy 18) and in two suspected due to
the combination of LTEC IV and comorbidities, but no pathogenic
variant was found. Tracheomalacia was diagnosed in every child
with additional tracheobronchial malformations in four patients
(3× shortened trachea or bronchus intermedius, 1× hypoplastic left
main bronchus). Dysphagia and gastroesophageal reflux were pre-
sent in every patient, microgastria in four patients diagnosed by
barium swallow test. Additionally, a Meckel's diverticulum and in-
testinal nonrotation were found in two children. Every child was
born with a congenital heart defect (seven children with atrial
septal defect type II, four with ventricular septal defect). Two
children developed hydrocephalus internus (one of unknown cause,
the other after intracerebral hemorrhage III°); in two other children
seizures were noted.
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TABLE 1 Patient characteristics
(a)
Patient 1 Patient 2 Patient 3 Patient 4
General information
Gender Female Male Female Male
Cleft typea III III III III
Distance from carina (mm) 35.0 22.0 20.0 26
Age at bronchoscopy (days) 24 27 19 3
Neonatal history
Polyhydramnios No nk No Yes
Cesarean section Yes Yes Yes No
Gestational age (weeks) 31 + 6 38 + 3 38 + 0 39 + 0
Postnatal respiratory support/









Birth weight (g/z‐scoreb) 1735/−0.01 3150/0.54 2820/−1.12 4310/−0.17
Birth length (cm/z‐scoreb) 45/0.78 49/−1.06 45/−2.65 56/1.78
Head circumference
(cm/z‐scoreb)
29.0/0.35 34.0/−0.80 nk 38.5/2.46
Comorbidity
Genetic syndrome No Opitz G/BBB M. Down No
Bronchial malformation Yes Yes No No
Tracheomalacia Yes Yes Yes Yes
Dysphagia Yes Yes Yes Yes
Gastroesophageal reflux Yes Yes Yes Yes
Gastrointestinal tract Microgastria Microgastria No No
Structural heart defect ASD II, VSD VSD VSD ASD II
Nervous system No No No Seizure
Treatment
Age at tracheal surgery 43 days 57 days 55 days 10 days
Tracheostomy Yes Yes Yes Yes
Jejunostomy Yes Yes Yes Yes
Outcome







Relapse Yes Yes Yes Yes
Duration of invasive ventilation 24months Ongoing Ongoing Ongoing
Recurrent aspirations Yes No Yes Yes
Hospitalization due to
respiratory tract infection
Yes Yes Yes Yes
Body weight at follow‐up
(z‐scoreb)













Patient 5 Patient 6 Patient 7 Patient 8 Patient 9
General information
Gender Female Male Male Female Male
Cleft typea IV IV IV IV IV
Distance from carina (mm) 2.5 0.7 8.0 8.0 8.0
Age at bronchoscopy (days) 11 1 4 3 3
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3.3 | Treatment
Due to respiratory insufficiency, all patients needed respiratory
support after birth: eight invasive and one non‐invasive ventila-
tion. For long‐term mechanical ventilation, tracheostomy was
planned for all children but only performed in seven, as one child
died before the intervention. Due to gastrointestinal comorbid-
ities (dysphagia, gastroesophageal reflux, and microgastria) in




Patient 5 Patient 6 Patient 7 Patient 8 Patient 9
Neonatal history
Polyhydramnios Yes Yes Yes Yes Yes
Cesarean section Yes Yes Yes No Yes
Gestational age (weeks) 36 + 2 30 + 4 37 + 1 32 + 2 35 + 5
Postnatal respiratory support/











Birth weight (g/z‐scoreb) 2720/−0.22 1680/0.37 2716/−0.94 1350/−1.23 2100/−1.58
Birth length (cm/z‐scoreb) 48/−0.29 42.5/0.4 52/0.70 40/−0.93 45/−1.42
Head circumference
(cm/z‐scoreb)
34.0/0.35 30.4/0.68 34.0/−0.32 29.5/−0.29 31/−1.62
Comorbidity
Genetic syndrome No Suspected No Monosomy 18 Suspected
Bronchial malformation Yes nk Yes No No
Tracheomalacia Yes nk Yes Yes Yes
Dysphagia Yes nk Yes Yes Yes
Gastroesophageal reflux Yes Yes Yes Yes Yes






Structural heart defect ASD II ASD II ASD II ASD II ASD II, VSD
Nervous system Hydrocephalus
internus






Age at tracheal surgery 13 days 3 days 9 days 38 days 7 days
Tracheostomy Yes Planned Yes Yes Yes
Jejunostomy Yes Yes Yes Yes Yes
Outcome
Period of follow‐up 3.2 years 34 days 6.9 years 9.2 months 6.4 years
Clinical course Clinically stable Deceased Clinically stable Clinically stable Clinically stable
Relapse Yes – No Yes No
Duration of invasive
ventilation
Ongoing Until death Ongoing Ongoing Ongoing
Recurrent aspirations Yes Yes Yes Yes Yes
Hospitalization due to
respiratory tract infection
Yes Yes Yes Yes Yes
Body weight at follow‐up
(z‐scoreb)














Abbreviations: ASD, atrium septum defect; CPAP, continuous positive airway pressure; ICH, intracerebral hemorrhage; nk, not known;
VSD, ventricle septum defect.
aAccording to Benjamin and Inglis.8
bThe data for z‐scores were taken from Fenton et al.29
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In the children diagnosed with LTEC type III tracheal surgery
was performed within the first 2 months of life, in children with LTEC
type IV within the first 4 weeks. In six patients, a stepwise surgical
approach for the repair of the tracheal cleft was undertaken. First,
the tracheoesophageal cleft was repaired up to the larynx;
6–20weeks later, after the patients had gained weight and were in a
cardiorespiratory stable condition, the laryngeal cleft was closed. In
three patients, a complete cleft repair was performed during one
surgical intervention. In two patients where a stable respiratory si-
tuation was difficult to achieve, jejunostomy was performed in
combination with a gastric inlet ligation as a first surgical interven-
tion to exclude gastroesophageal reflux and reduce gas leakage
complicating mechanical ventilation. The gastric ligation was re-
moved later during the final repair of the tracheal cleft.
3.4 | Clinical course and outcome
In all except one case, the long‐term courses were reported as
clinically stable at the last follow‐up visit. One patient died from
multiorgan failure due to sepsis at the age of 43 days. Follow‐up data
of eight surviving patients were available (median: 5.2 years, range:
0.51–15.7 years). Relapses of the cleft restricted to the larynx oc-
curred in all but two patients. Due to severe tracheomalacia at the
time of the latest follow‐up visit all children except one (duration of
invasive ventilation 24months) were still on home mechanical ven-
tilation due to tracheomalacia and in some cases additional bronchial
malformations. For all but one child recurrent aspirations were re-
ported and repeated hospitalizations due to recurrent respiratory
tract infections and pneumonias were necessary for all patients.
Except in two patients, poor weight gain was noted in every patient
(median z‐score for weight at the last follow‐up: −1.67, range: −11.3
to −0.13) despite high‐calorie nutrition via jejunostomy tubes. At the
last follow‐up, three children were reported with a normal neurolo-
gical development, two children with delayed psychomotor devel-
opment, and four with motor function and cognitive defects. Of note,
in half of the patients, obstruction or dislocation of the tracheostomy
cannula led to resuscitation events without further sequelae.
4 | DISCUSSION
In this study, we have analyzed a cohort of children diagnosed with
long segment LTEC types III and IV. Key findings were that (1) all
patients had additional tracheobronchial, gastrointestinal, or cardiac
malformations, (2) almost half of the patients were diagnosed with a
genetic syndrome, (3) mortality rate decreased compared to previous
reports, (4) long‐term morbidity is substantial although (5) a good
clinical long‐term outcome can be achieved in the majority of cases.
Additionally, we have reviewed and compiled all cases reported in
the literature up to now (Table 2) and compared those data to the
findings of the present report (Table S1a,b). Overall there was good
agreement of our findings with the published data. However, there
were several areas of interest and novelty.
In our cohort we found a strong association between long seg-
ment LTECs and additional comorbidities (Table 2). This is in line
with previously published data reporting an absence of additional
malformations in only a small proportion of patients. Although a
coincidental association of these different conditions cannot be ex-
cluded, this seems unlikely due to the rarity of the single diseases.
We were able to identify a genetic syndrome more often than pub-
lished before. Taken together, it may be speculated that long seg-
ment LTEC could be the cause or consequence of a more extended
developmental disturbance and not an entity in itself.
Compared with published cases, children in our cohort were
more often preterm. Furthermore, in our cohort only one patient
died during the neonatal period following sepsis with multiorgan
failure, whereas much higher mortality rates are published. We as-
sume that a multidisciplinary team with improved intensive care,
advanced surgical procedures, and increased awareness of asso-
ciated malformations contribute most to reduce the previously re-
ported high mortality rate in the neonatal period.12–14
All patients suffered from severe tracheomalacia, making a tra-
cheostomy for long‐term mechanical ventilation necessary, although
we did not notice severe chronic lung disease or neuromuscular
weakness. The tracheomalacia remains significant after surgery due
to the abnormal tracheal wall structure and often‐occurring re-
dundancy of the surgically created posterior tracheal wall.14 Due to
cleft relapse and pulmonary infections, repeated hospitalizations
were necessary. We think that persistent gastroesophageal reflux
found in every patient of our cohort might be a major contributing
factor and therefore should be treated early. Furthermore, every
patient of our cohort was diagnosed with dysphagia and almost half
of the children with microgastria. It has to be noted that yet failure
to thrive was present in seven of the children despite jejunostomy,
F IGURE 1 Proposed classification for laryngeal clefts by
Benjamin and Inglis.8 (A) Type I extends to the level of vocal cords,
(B) type II extends below vocal cords into cricoid cartilage, (C) type
III extends through cricoid cartilage to cervical trachea/esophagus,
and (D) type IV extends to the level of thoracic trachea.
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high‐calorie nutrition, and absence of intestinal problems. A recent
study found coexisting neuromuscular dysfunction or dyscoordina-
tion in patients with LTECs contributing to dysphagia and aspira-
tion.28 This is in accordance with our findings reporting normal
neurological development in less than half of the patients. Finally,
congenital heart defects were reported more often in our cohort.
Therefore, echocardiography should be performed early.
Our patient cohort indicates that a stable long‐term clinical
outcome can be achieved. Morbidity was mostly influenced by (1)
aspirations and recurrent respiratory tract infection and (2) often‐
occurring relapses of the cleft.2–4,23,25
We did not find relevant differences regarding additional mal-
formations between LTEC III and IV (Table 2). As other authors have
noted,15 the LTEC III patients in our series may confirm the het-
erogeneity of this group where more extensive type III lesions show
substantial more comorbidity than type III lesions with less distal
extension of the cleft.
This study has several limitations. The data were collected ret-
rospectively, therefore the clinical management was variable. Fur-
thermore, although we report severe morbidity caused by additional
malformations and often occurring relapses, it is not possible to draw
conclusions to the quality of life as we did not analyze patient or
caregiver‐reported outcomes. Recommendations for optimal medical
care derived from this study should be handled carefully as the
sample size of only nine patients is small. Nevertheless, our findings
were put into the perspective of a review of all published cases and
focus on morbidity and long‐term outcomes in contrast to previous
publications, mainly concentrating on various surgical procedures.
In summary, long segment LTECs are mostly associated with ad-
ditional tracheobronchial, gastrointestinal, and cardiac malformations
that have a major influence on morbidity, although low mortality can
be achieved. We suggest that for optimal long‐term outcome, patients
should be followed carefully by a multidisciplinary team.
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TABLE 2 Studies on laryngeal clefts types III and IV until 2020





























Clinically stable 71% 34% 46% 89%
Deceased 29% 66% 54% 11%
Disease
associated
75% 88% 87% 100%
Surgery
associated
25% 12% 13% 0%
Recurrent
aspirations
94% 100% 97% 100%
Tracheostoma 71% 89% 80% 100%
Long time ventilation 43% 81% 61% 100%
Gastrostomy/PEG 67% 90% 80% 100%
Jejunostomy/PEJ 20% 45% 33% 100%
Genetic syndromes 19% 10% 13% 44%
No malformations 4% 1% 2% 0%
Gastrointestinal
malformations
24% 32% 29% 55%
Micorgastria 50% 79% 58% 80%
Bronchial
malformations
19% 28% 25% 88%
Cardiovascular
malformations
13% 16% 15% 100%
CoA 0% 40% 33% 0%
VSD 50% 20% 25% 44%
ASD 0% 20% 17% 77%
Urogenital
malformations




13% 8% 10% 77%
Skeletal
malformations
14% 7% 10% 0%
Diaphragmatic
hernia
3% 4% 3% 0%
Abbreviations: ASD, atrial septal defect; CoA, coarctation of the aorta;
PDA, patent ductus arteriosus; PEG, percutaneous endoscopic
gastrostomy; PEJ, percutaneous endoscopic jejunostomy;
VSD, ventricular septal defect.
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